Aytu BioScience share price logo

Aytu BioScience

NASDAQ: AYTU

$2.13

-0.06

(-2.74%)

as on

Aytu BioScience Stock Performance

as on September 10, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.14
    $2.24
    downward going graph

    -0.47%

    Downside

    5.16%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.65
    $3.07
    downward going graph

    22.53%

    Downside

    43.90%

    Upside

    downward going graph

Aytu BioScience share price movements today

Previous Close
$2.19
Open
$2.24
Volume
278.7K
Market Cap
$23.7M
Day's Low - High
$2.14 - $2.24
52 Week Low - High
$1.65 - $3.07

Aytu BioScience Historical Returns

1 Month Return
-7.2 %
3 Month Return
-4.78 %
1 Year Return
-6.01 %
3 Year Return
+ 32.73 %
5 Year Return
-96.73 %

Aytu BioScience Stock Fundamentals & Key Indicators

Check Aytu BioScience market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.7M

EPS (TTM)

-1.135

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-2.6M

Revenue (TTM)

56.6M

Profit Margin

-60.17%

Return On Equity TTM

-97.42%

Aytu BioScience vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aytu BioScience with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$23.7M-96.73%NA-60.17%NA
BUY$20.9B136.13%16.4786.14%NA
HOLD$19.4B16.24%-46.1434.83%2.8899999999999997%
BUY$40.9BNA19.5914.55%134.02%
BUY$31.3B-64.29%12.1170.87%2.8400000000000003%

Stock Returns calculator for Aytu BioScience Stock including INR - Dollar returns

The Aytu BioScience stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Aytu BioScience investment value today

Current value as on today

₹98,519

Returns

-₹1,481

(-1.48%)

Returns from Aytu BioScience Stock

-₹8,584 (-8.58%)

Dollar Impact

₹7,103 (+7.1%)

Analyst Recommendation on Aytu BioScience Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Aytu BioScience. Average target price of $9.5

Aytu BioScience Share Price Target

Get share price movements and forecasts by analysts on Aytu BioScience.

What analysts predicted

77.58%UPSIDE

Target Price

$9.5

Current Price

$2.13

Analyzed by

1 Analysts

Target

$9.50

Aytu BioScience target price $9.5, a slight upside of 77.58% compared to current price of $2.13. According to 1 analysts rating.

Indian Investors' Interest in Aytu BioScience Stock

Search interest for Aytu BioScience Stock has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-45% versus previous 30 day period

Aytu BioScience Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
18
14
17
16
16
18
15
13
15
12
Gross Profit
14
10
11
11
10
12
10
9
9
6
Operating Income
3
-1
-3
0
-1
2
-7
-1
-1
-4
EBITDA
4
1
-5
3
2
6
-17
3
-9
-4
Interest Expense
1
1
4
0
1
0
0
0
0
0
Depreciation
2
1
1
1
1
1
1
0
0
1
Income Before Tax
1
-1
-3
1
0
3
-19
1
-10
-5
Income Tax Expense
0
0
0
0
0
0
0
-
-
0
Net Income
0
-2
-4
1
0
3
-19
1
-10
-5
Net Profit Margin
-1.17%
-20.58%
-25.68%
8.89%
4.86%
21.65%
-130.94%
14.15%
-69.79%
-45.27%

Aytu BioScience Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
2
3
3
7
27
65
96
107
65
66
Gross Profit
1
1
1
5
19
29
50
66
49
45
Operating Income
-21
-20
-19
-16
-21
-58
-109
-17
-1
-7
EBITDA
-21
-18
-15
-14
-12
-29
-27
-3
1
-4
Interest Expense
5
2
0
-
-
37
147
4
4
3
Depreciation
-
4
2
2
6
9
10
4
8
5
Income Before Tax
-28
-22
-10
-27
-13
-58
-108
-17
-10
-13
Income Tax Expense
8
1
-2
20
-9
0
0
0
2
0
Net Income
-28
-22
-10
-47
-13
-58
-108
-17
-15
-13
Net Profit Margin
-1099.73%
-698.67%
-278.36%
-644.33%
-49.29%
-88.81%
-112.53%
-15.88%
-24.31%
-20.43%

Aytu BioScience Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-2
-4
1
0
3
-19
1
-10
-5
Operating Cash Flow
0
0
-1
2
-6
2
0
3
-4
Investing Cash Flow
0
0
0
0
0
-3
-
0
-
Financing Cash Flow
0
1
0
-2
4
12
2
-6
0
Change in Cash
0
0
0
0
-2
12
1
-2
-3

Aytu BioScience Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-22
-10
-27
-13
-58
-108
-17
-15
-13
Operating Cash Flow
-13
-15
-13
-28
-25
-28
-5
-1
-1
Investing Cash Flow
-3
0
-1
-5
-2
-3
0
0
-2
Financing Cash Flow
10
22
19
71
30
1
8
-1
15
Change in Cash
-7
6
4
37
1
-30
3
-2
10

Mutual Funds that own Aytu BioScience Stock

Check out the Mutual Funds with significant holdings in Aytu BioScience.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.33058%
250146
Fidelity Concord Street Trust
0.594388%
63797
Perritt Funds Inc
0.186337%
20000
NORTHERN LIGHTS FUND TRUST II
0.186337%
20000
DFA INVESTMENT DIMENSIONS GROUP INC
0.105196%
11291

Global Institutional Holdings in Aytu BioScience

Funds
Holdings
Vanguard
2.43%
Dimensional
0.14%

Insights on Aytu BioScience

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -10.58M → -5.61M (in $), with an average increase of 88.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 58.9% return, outperforming this stock by 64.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 64.3% return, outperforming this stock by 31.6%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 15.16M → 12.41M (in $), with an average decrease of 18.2% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, AYTU stock has moved down by -3.9%

About Aytu BioScience

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
OrganisationAytu BioScience
HeadquartersDenver Corporate Center III, Denver, CO, United States, 80237
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Joshua R. Disbrow
E-voting on sharesClick here to vote

Key Management of Aytu BioScience

Name

Title

Mr. Joshua R. Disbrow

CEO & Director

Mr. Ryan J. Selhorn CPA

CFO, Corporate Secretary & Treasurer

Mr. Jarrett T. Disbrow Ph.D.

Chief Business Officer

Mr. Greg Pyszczymuka

Chief Commercial Officer

Ms. Margaret Cabano

Vice President of Operations

Dr. Gerwin Westfield Ph.D.

Senior Vice President of Scientific Affairs

FAQs

What is Aytu BioScience share price today?

Aytu BioScience share price today is $2.13 as on at the close of the market. Aytu BioScience share today touched a day high of $2.24 and a low of $2.14.

What is the 52 week high and 52 week low for Aytu BioScience share?

Aytu BioScience share touched a 52 week high of $3.07 on and a 52 week low of $1.65 on . Aytu BioScience stock price today i.e. is closed at $2.13,which is 30.51% down from its 52 week high and 29.08% up from its 52 week low.

What is Aytu BioScience's market capitalisation today?

Aytu BioScience market capitalisation is $0.00T as on .

How to invest in Aytu BioScience Stock (AYTU) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aytu BioScience on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aytu BioScience Shares that will get you 0.7042 shares as per Aytu BioScience share price of $2.13 per share as on September 10, 2026 at 1:29 am IST.

What is the minimum amount required to buy Aytu BioScience Stock (AYTU) from India?

Indian investors can start investing in Aytu BioScience (AYTU) shares with as little as ₹95.105 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹951.05 in Aytu BioScience stock (as per the Rupee-Dollar exchange rate as on ). Based on Aytu BioScience share’s latest price of $2.13 as on September 10, 2026 at 1:29 am IST, you will get 4.6948 shares of Aytu BioScience. Learn more about fractional shares .

What are the returns that Aytu BioScience has given to Indian investors in the last 5 years?

Aytu BioScience stock has given -96.73% share price returns and 28.48% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?